Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 23
- −2 vs. Q1 2022
- Portfolio value
- $501.5M
- +$123.4M (+32.6%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LEGNLegend Biotech Corp | SPONSORED ADS | 978,596 | $53.8M | 10.7% | +146,868+17.7% | Added | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 1,445,566 | $46.2M | 9.2% | +478,739+49.5% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 659,968 | $44.3M | 8.8% | +561,585+570.8% | Added | History |
| SRRASierra Oncology, Inc. | COM NEW | 801,314 | $44.1M | 8.8% | +30,000+3.9% | Added | History |
| INCYIncyte Corp | COM | 556,043 | $42.2M | 8.4% | +321,624+137.2% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 432,170 | $40.2M | 8.0% | +110,549+34.4% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 163,066 | $38.4M | 7.7% | +87,431+115.6% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 88,816 | $33.7M | 6.7% | +88,816 | New | History |
| IMCRImmunocore Holdings plc | ADS | 667,417 | $24.9M | 5.0% | +168,227+33.7% | Added | History |
| ARVNArvinas, Inc. | COM | 517,406 | $21.8M | 4.3% | +26,073+5.3% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,048,516 | $17.6M | 3.5% | +1,048,516 | New | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 876,156 | $16.9M | 3.4% | +174,800+24.9% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,306,569 | $15.1M | 3.0% | +50,518+4.0% | Added | History |
| MRUSMerus N.V. | COM | 452,244 | $10.2M | 2.0% | +202,506+81.1% | Added | History |
| ESPREsperion Therapeutics, Inc. | COM | 1,408,050 | $8.96M | 1.8% | +250,804+21.7% | Added | History |
| TGTXTG Therapeutics, Inc. | COM | 1,964,709 | $8.35M | 1.7% | +1,964,709 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 826,779 | $7.04M | 1.4% | +490,550+145.9% | Added | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 148,216 | $7.01M | 1.4% | +148,216 | New | History |
| VORVor Biopharma Inc. | COM | 1,304,300 | $6.48M | 1.3% | +409,896+45.8% | Added | History |
| OYSTOyster Point Pharma, Inc. | COM | 1,333,330 | $5.77M | 1.2% | +345,632+35.0% | Added | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 783,445 | $4.31M | 0.9% | 00.0% | Unchanged | – |
| LQDALiquidia Corp | COM NEW | 850,961 | $3.71M | 0.7% | +850,961 | New | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 73,149 | $552.0K | 0.1% | −426,347−85.4% | Reduced | History |
Sold out since Q1 2022 (7)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| ISEEIVERIC bio, Inc. | COM | 910,416 | $15.3M | 4.1% | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 907,428 | $15.1M | 4.0% | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 136,243 | $14.3M | 3.8% | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 287,577 | $13.3M | 3.5% | History |
| PRTAProthena Corp Public Ltd Co | SHS | 267,946 | $9.80M | 2.6% | History |
| KYMRKymera Therapeutics, Inc. | COM | 227,034 | $9.61M | 2.5% | History |
| FULCFulcrum Therapeutics, Inc. | COM | 212,961 | $5.04M | 1.3% | History |